Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Tonix Pharm Holdings (TNXP)

Tonix Pharm Holdings (TNXP)
17.87 +0.68 (+3.96%) 10:56 ET [NASDAQ]
17.77 x 11 17.92 x 100
Realtime by (Cboe BZX)
17.77 x 11 17.92 x 100
Realtime 17.11 -0.08 (-0.47%) 09:29 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Tonix Pharm Holdings 26 MAIN STREET SUITE 101 CHATHAM NJ 07928 USA

www.tonixpharma.com Employees: 57 P: 862-799-8599 F: 212-923-5700

Sector:

Medical

Description:

Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 110,616
Enterprise Value, $K 19,326
Shares Outstanding, K 6,435
Annual Sales, $ 10,090 K
Annual Net Income, $ -130,040 K
Last Quarter Sales, $ 2,580 K
Last Quarter Net Income, $ -22,110 K
EBIT, $ -136,700 K
EBITDA, $ -132,440 K
60-Month Beta 1.50
% of Insider Shareholders 0.03%
% of Institutional Shareholders 82.26%
Float, K 6,433
% Float 99.97%
Short Volume Ratio 0.52

Growth:

1-Year Return -96.67%
3-Year Return -99.98%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -9.77 on 03/18/25
Next Earnings Date 05/12/25 [--]
Earnings Per Share ttm -2,535.85
EPS Growth vs. Prev Qtr 57.52%
EPS Growth vs. Prev Year 99.64%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 02/05/25

TNXP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -142.89%
Return-on-Assets % -112.21%
Profit Margin % -1,288.80%
Debt/Equity 0.05
Price/Sales 10.85
Price/Cash Flow N/A
Price/Book 0.53
Book Value/Share 31.79
Interest Coverage -0.31
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.